Chuan Gu

Key Laboratory Of National Health Commission For Critical Care And Emergency Medicine, Key Laboratory Of Chinese Academy Of Medical Sciences For Organ Transplantation, Tianjin Key Laboratory For Organ Transplantation
Tianjin, 300192, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Central Nervous System Efficacy of Furmonertinib (AST2818) Versus Gefitinib as First-Line Treatment for EGFR-Mutated NSCLC: Results From the FURLONG Study.

Central Nervous System Efficacy of Furmonertinib (AST2818) Versus Gefitinib as First-Line Treatment for EGFR-Mutated NSCLC: Results From the FURLONG Study.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 06, 2022

The Lateral Orbital Thickening and the Lateral Brow Thickening: A New Choice for the Lower Eyelid Suspension.

The Lateral Orbital Thickening and the Lateral Brow Thickening: A New Choice for the Lower Eyelid Suspension.

Journal: The Journal of craniofacial surgery

Published: March 07, 2022

Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study.

Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study.

Journal: The Lancet. Respiratory medicine

Published: January 07, 2022

Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.

Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.

Journal: The Lancet. Respiratory medicine

Published: July 14, 2020

A twenty-year review of clinical liver transplantation

A twenty-year review of clinical liver transplantation

Journal: Zhonghua wei zhong bing ji jiu yi xue

Published: March 28, 2019

CXC Chemokine Receptor Type 4 Antagonism Ameliorated Allograft Fibrosis in Rat Kidney Transplant Model.

CXC Chemokine Receptor Type 4 Antagonism Ameliorated Allograft Fibrosis in Rat Kidney Transplant Model.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

Published: June 07, 2017

MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39.

MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39.

Journal: BioMed research international

Published: August 10, 2016

Prolonged ischemia elicits acute allograft rejection involved in CXCR3 activation in rat kidney transplants.

Prolonged ischemia elicits acute allograft rejection involved in CXCR3 activation in rat kidney transplants.

Journal: Transplant immunology

Published: June 15, 2015

MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.

MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.

Journal: IUBMB life

Published: August 14, 2014

Maturation induction of human peripheral blood mononuclear cell-derived dendritic cells.

Maturation induction of human peripheral blood mononuclear cell-derived dendritic cells.

Journal: Experimental and therapeutic medicine

Published: February 27, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026